Get the Stockscreener App
2.27
12.94%
0.26
After Hours:
2.10
-0.17
-7.49%
Cytomed Therapeutics Ltd stock is traded at $2.27, with a volume of 64,487.
It is up +12.94% in the last 24 hours and up +28.25% over the past month.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
See More
Previous Close:
$2.01
Open:
$2
24h Volume:
64,487
Relative Volume:
5.67
Market Cap:
$23.28M
Revenue:
-
Net Income/Loss:
$-3.15M
P/E Ratio:
-7.4377
EPS:
-0.3052
Net Cash Flow:
$-2.23M
1W Performance:
+17.62%
1M Performance:
+28.25%
6M Performance:
-12.69%
1Y Performance:
+52.35%
1-Day Range:
$2.00
$2.27
1-Week Range:
$1.82
$2.27
52-Week Range:
$1.20
$4.0499
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Name
Cytomed Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare GDTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
2.27 | 23.28M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomed Therapeutics Ltd Stock (GDTC) Latest News
Published on: 2025-09-12 00:42:12 - Newser
Does CytoMed Therapeutics Limited show high probability of rebound2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
What high frequency data says about CytoMed Therapeutics LimitedWatch List & Fast Moving Stock Trade Plans - Newser
Has CytoMed Therapeutics Limited found a price floorJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Volatility clustering patterns for CytoMed Therapeutics Limited2025 Major Catalysts & Growth Oriented Trading Recommendations - Newser
Is CytoMed Therapeutics Limited reversing from oversold territoryTrade Entry Summary & Free Daily Entry Point Trade Alerts - Newser
Order flow analysis tools used on CytoMed Therapeutics LimitedWeekly Trend Recap & Free Weekly Watchlist of Top Performers - Newser
Price Reversal in CytoMed Therapeutics Limited Traders Watch Closely2025 Growth vs Value & Accurate Buy Signal Alerts - beatles.ru
What moving averages say about CytoMed Therapeutics LimitedTrend Reversal & Low Risk Entry Point Guides - Newser
Is CytoMed Therapeutics Limited stock reversal real or fakeInsider Selling & Long-Term Capital Growth Ideas - Newser
Will CytoMed Therapeutics Limited outperform tech stocksProfit Target & Free Weekly Watchlist of Top Performers - خودرو بانک
Comparing CytoMed Therapeutics Limited in custom built stock radarsJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
Is it time to cut losses on CytoMed Therapeutics LimitedBreakout Watch & Verified Momentum Stock Alerts - Newser
Is CytoMed Therapeutics Limited stock poised for growthMarket Movement Recap & AI Driven Price Forecasts - Newser
Predicting CytoMed Therapeutics Limited trend using moving averagesEarnings Miss & Technical Entry and Exit Alerts - Newser
Is CytoMed Therapeutics Limited building a consolidation baseQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
What indicators show strength in CytoMed Therapeutics LimitedJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - Newser
How to build a custom watchlist for CytoMed Therapeutics LimitedWeekly Trend Report & Proven Capital Preservation Tips - Newser
Best data tools to analyze Adlai Nortye Ltd. Depositary Receipt stockQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Why is CytoMed Therapeutics Limited stock going downQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Price action breakdown for Sunnova Energy International Inc.Insider Selling & Weekly Return Optimization Plans - Newser
Applying sector rotation models to CytoMed Therapeutics LimitedWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
What to do if you’re stuck in TLYS2025 Investor Takeaways & Target Return Focused Picks - Newser
Is FGI Industries Ltd. Equity Warrant stock reversal real or fakeRate Cut & Low Risk Investment Opportunities - Newser
Is Integral Ad Science Holding Corp. stock bottoming outJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Will CytoMed Therapeutics Limited bounce back from current supportJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
How to interpret RSI for ATOS stock2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
How to read the order book for WhiteHorse Finance Inc.Sell Signal & Safe Entry Momentum Tips - Newser
can momentum traders help lift phin2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Taysha Gene Therapies Inc. stock volume spike explainedChart Signals & Free Fast Gain Swing Trade Alerts - Newser
Signal strength of G. Willi Food International Ltd. stock in tech scannersMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Should you hold or exit Zai Lab Limited Depositary Receipt nowGap Up & Weekly Momentum Stock Picks - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.2025 Trading Volume Trends & Fast Gain Stock Trading Tips - Newser
Using flow based indicators on Aemetis Inc.Market Performance Recap & Expert Verified Movement Alerts - Newser
Will earnings trigger a reversal in ACONJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Is this a good reentry point in CytoMed Therapeutics LimitedProduct Launch & Fast Exit and Entry Strategy Plans - Newser
Multi asset correlation models including Merus N.V.Insider Selling & Technical Entry and Exit Tips - Newser
Will a bounce in CytoMed Therapeutics Limited offer an exit2025 Market Sentiment & Reliable Price Action Trade Plans - Newser
Price action breakdown for Nayax Ltd.2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Is WSO.B building a consolidation baseJuly 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Risk adjusted return profile for EXPE analyzed2025 Volatility Report & Community Shared Stock Ideas - Newser
Is SIFCO Industries Inc. forming a reversal patternJobs Report & Verified Short-Term Plans - Newser
Should you wait for a breakout in GBLIStock Surge & AI Driven Price Predictions - Newser
Can you recover from losses in RADCOM Ltd.2025 Sector Review & Short-Term High Return Strategies - Newser
How to build a dashboard for CytoMed Therapeutics Limited stockCEO Change & Weekly Watchlist for Hot Stocks - Newser
What institutional flow reveals about CytoMed Therapeutics LimitedEarnings Overview Summary & Smart Money Movement Alerts - Newser
Is X4 Pharmaceuticals Inc. trending in predictive chart modelsTrade Performance Summary & Verified High Yield Trade Plans - Newser
Is it time to cut losses on MBINLJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Real time scanner hits for CBOE explainedWeekly Earnings Recap & Low Drawdown Investment Strategies - Newser
Full technical analysis of MSCI Inc. stock2025 Volatility Report & Reliable Trade Execution Plans - Newser
Kyverna Therapeutics Inc. stock prediction for this week2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - Newser
Cytomed Therapeutics Ltd Stock (GDTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):